US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Gilead Sciences

138.55

-1.2200-0.87%

Post-market: 138.590.0400+0.03%19:44 EDT

Volume:3.43M

Turnover:475.85M

Market Cap:171.90B

PE:20.44

High:140.27

Open:138.61

Low:137.75

Close:139.77

52wk High:157.29

52wk Low:93.37

Shares:1.24B

Float Shares:1.24B

Volume Ratio:0.72

T/O Rate:0.28%

Dividend:3.16

Dividend Rate:2.28%

EPS(TTM):6.78

EPS(LYR):6.78

ROE:40.66%

ROA:12.52%

PB:7.57

PE(LYR):20.44

Loading ...

Overview Company News Filings

Morgan Stanley Reaffirms Their Buy Rating on Gilead Sciences (GILD)

Cantor Fitzgerald Adjusts Price Target on Gilead Sciences to $115 From $155, Maintains Overweight Rating

MT Newswires Live

Gilead expects Q1 acquired IPR&D charge of about $107 million

Tempus AI announce strategic collaboration with Gilead

BUZZ-Tempus AI rises as it expands cancer research partnership with Gilead

Tempus Announces Strategic Collaboration With Gilead to Advance Oncology R&D Through RWE

THOMSON REUTERS

Tempus expands multi-year oncology RWE collaboration with Gilead Sciences

Assembly Bio highlights positive Phase 1b HSV data for ABI-5366 at ESCMID 2026

Cartography Biosciences: Advances Strategic Oncology Collaboration With Gilead's First Option Target Exercise

THOMSON REUTERS

BUZZ-Kymera rises as Gilead pays $45 million for experimental cancer drug

Kymera Therapeutics Announces Gilead Sciences’ Option Exercise to License KT-200, Oral CDK2 Molecular Glue Degrader Development Candidate

Gilead Sciences Inc. Stock Rises Wednesday, Still Underperforms Market

Gilead Sciences' Tubulis Buy Underscores Shift Beyond HIV, Oppenheimer Says

MT Newswires Live

Gilead price target raised to $155 from $152 at Truist

BUZZ-Truist lifts Gilead PT on expectations of in-line Q1 results

Gilead Sciences: Strategic Oncology Expansion and Undervalued Growth Opportunity Driving Buy Rating

Gilead’s Tubulis Acquisition: Building an ADC Oncology Franchise and Enhancing Risk‑Reward for GILD Shares

Leerink says Tubulis deal highlights value of ADC platforms like Sutro’s

Leerink sees Gilead’s $5B Tubulis buy as ‘more than an oncology bolt-on’

Gilead Sciences (GILD) Gets a Buy from Cantor Fitzgerald

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/GILD/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GILD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GILD\",,,,,undefined,":{"symbol":"GILD","market":"US","secType":"STK","nameCN":"Gilead Sciences","latestPrice":138.55,"timestamp":1776369600000,"preClose":139.77,"halted":0,"volume":3432531,"hourTrading":{"tag":"盘后","latestPrice":138.59,"preClose":138.55,"latestTime":"19:44 EDT","volume":255739,"amount":35432736.7308,"timestamp":1776383045853,"change":0.04,"changeRate":0.000289,"amplitude":0.001083},"delay":0,"changeRate":-0.008728625599198675,"floatShares":1238162880,"shares":1240679623,"eps":6.78,"marketStatus":"Not Yet Opened","change":-1.22,"latestTime":"04-16 16:00:00 EDT","open":138.61,"high":140.265,"low":137.75,"amount":475845765.60075,"amplitude":0.017994,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":6.78,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1776412800000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":696056400000,"exchange":"NASDAQ","adjPreClose":139.77,"dividendRate":0.022808,"preHourTrading":{"tag":"盘前","latestPrice":138.83,"preClose":139.77,"latestTime":"09:29 EDT","volume":3335,"amount":464430.4992,"timestamp":1776346199999,"change":-0.94,"changeRate":-0.006725,"amplitude":0.012449},"postHourTrading":{"tag":"盘后","latestPrice":138.59,"preClose":138.55,"latestTime":"19:44 EDT","volume":255739,"amount":35432736.7308,"timestamp":1776383045853,"change":0.04,"changeRate":0.000289,"amplitude":0.001083},"volumeRatio":0.716529,"impliedVol":0.3429,"impliedVolPercentile":0.624},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GILD\",,,,,undefined,":{"symbol":"GILD","floatShares":1238162880,"roa":"12.52%","roe":"40.66%","lyrEps":6.78,"volumeRatio":0.716529,"shares":1240679623,"dividePrice":3.16,"high":140.265,"amplitude":0.017994,"preClose":139.77,"low":137.75,"week52Low":93.37,"pbRate":"7.57","psRate":"5.84","week52High":157.29,"institutionHeld":0.8716,"latestPrice":138.55,"eps":6.78,"divideRate":0.022808,"volume":3432531,"delay":0,"ttmEps":6.78,"open":138.61,"prevYearClose":122.74,"prevWeekClose":138.99,"prevMonthClose":139.37,"prevQuarterClose":139.37,"fiveDayClose":142.09,"twentyDayClose":141.29,"sixtyDayClose":124.14,"dividendPayoutRate":0.46193184575686363,"dividendFrequency":"Q","dividendGrowthYears":10,"dividendGrowthRate":0.025974025974025997,"fiveYearAvgDividendRate":0.03377732217604273},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GILD\",params:#limit:5,,,undefined,":[{"date":"2026-03-13","symbol":"GILD","amount":0.82,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-13","defaultRemindTime":1773408600000,"name":"吉利德科学","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-30","payableDate":"2026-03-13","currency":"USD","dateTimestamp":1773374400000,"payDate":"2026-03-30"},{"market":"US","date":"2026-02-10","symbol":"GILD","fiscalQuarterEnding":"2025/12","expectedEps":1.83,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1770699600000,"reportTimeType":"post","actualEps":1.9},{"date":"2025-12-15","symbol":"GILD","amount":0.79,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-15","defaultRemindTime":1765809000000,"name":"吉利德科学","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-30","payableDate":"2025-12-15","currency":"USD","dateTimestamp":1765774800000,"payDate":"2025-12-30"},{"market":"US","date":"2025-10-30","symbol":"GILD","fiscalQuarterEnding":"2025/09","expectedEps":2.15,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1761796800000,"reportTimeType":"post","actualEps":2.47},{"date":"2025-09-15","symbol":"GILD","amount":0.79,"announcedDate":"2025-08-07","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-15","defaultRemindTime":1757943000000,"name":"吉利德科学","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-29","payableDate":"2025-09-15","currency":"USD","dateTimestamp":1757908800000,"payDate":"2025-09-29"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GILD\",market:\"US\",,,undefined,":[{"executeDate":"2016-06-14","recordDate":"2016-06-16","paymentDate":"2016-06-29","value":0.47,"currency":"USD"},{"executeDate":"2016-09-14","recordDate":"2016-09-16","paymentDate":"2016-09-29","value":0.47,"currency":"USD"},{"executeDate":"2016-12-13","recordDate":"2016-12-15","paymentDate":"2016-12-29","value":0.47,"currency":"USD"},{"executeDate":"2017-03-14","recordDate":"2017-03-16","paymentDate":"2017-03-30","value":0.52,"currency":"USD"},{"executeDate":"2017-06-14","recordDate":"2017-06-16","paymentDate":"2017-06-29","value":0.52,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GILD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2727,"buy":0.5152,"hold":0.2121,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5152,"analysts":33,"updateTime":1773201600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GILD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GILD","date":"2026-04-15","current":20.435103,"percent":0.50817,"low":11.012226,"twenty":16.795866,"median":20.244608,"eighty":105.247898,"high":985.638037,"avg":106.5062,"sd":214.310135,"marketCap":174329631725},"quantilePoints":[{"date":"2021-04-16","current":684.496566,"twenty":5.886815,"median":14.653082,"eighty":31.596225,"marketCap":84193077595},{"date":"2021-04-23","current":670.268209,"twenty":5.886815,"median":14.712213,"eighty":42.207393,"marketCap":82442989695},{"date":"2021-04-30","current":265.489326,"twenty":5.886815,"median":14.778694,"eighty":42.567879,"marketCap":79912287049},{"date":"2021-05-07","current":277.252542,"twenty":5.886815,"median":14.856386,"eighty":42.894314,"marketCap":83453015165},{"date":"2021-05-14","current":285.544285,"twenty":5.886815,"median":14.904321,"eighty":43.205482,"marketCap":85948829715},{"date":"2021-05-21","current":286.46096,"twenty":5.886815,"median":15.044244,"eighty":43.463811,"marketCap":86224748912},{"date":"2021-05-28","current":275.460859,"twenty":5.886815,"median":15.158818,"eighty":43.913538,"marketCap":82913718554},{"date":"2021-06-04","current":280.960909,"twenty":5.886815,"median":15.193582,"eighty":44.006301,"marketCap":84569233733},{"date":"2021-06-11","current":286.544294,"twenty":5.886815,"median":15.256684,"eighty":44.397317,"marketCap":86249832475},{"date":"2021-06-18","current":277.544211,"twenty":5.886815,"median":15.331847,"eighty":44.793017,"marketCap":83540807637},{"date":"2021-06-25","current":282.835927,"twenty":5.886815,"median":15.396911,"eighty":44.953898,"marketCap":85133613908},{"date":"2021-07-02","current":288.752648,"twenty":5.886815,"median":15.472548,"eighty":45.316733,"marketCap":86914546903},{"date":"2021-07-09","current":284.252606,"twenty":5.886815,"median":15.579206,"eighty":45.697022,"marketCap":85560034484},{"date":"2021-07-16","current":285.960955,"twenty":5.886815,"median":15.726234,"eighty":45.841484,"marketCap":86074247532},{"date":"2021-07-23","current":287.58597,"twenty":5.886815,"median":15.752152,"eighty":47.568365,"marketCap":86563377017},{"date":"2021-07-30","current":16.591985,"twenty":5.886815,"median":15.856378,"eighty":51.009533,"marketCap":85647826956},{"date":"2021-08-06","current":16.706124,"twenty":5.886815,"median":15.9165,"eighty":51.009533,"marketCap":86237013283},{"date":"2021-08-13","current":17.284208,"twenty":5.886815,"median":16.177233,"eighty":51.009533,"marketCap":89221079750},{"date":"2021-08-20","current":17.59511,"twenty":5.886815,"median":16.446515,"eighty":51.009533,"marketCap":90825955833},{"date":"2021-08-27","current":17.313355,"twenty":5.886815,"median":16.628399,"eighty":51.009533,"marketCap":89371536883},{"date":"2021-09-03","current":17.478521,"twenty":5.886815,"median":16.94972,"eighty":51.009533,"marketCap":90224127302},{"date":"2021-09-10","current":17.242916,"twenty":5.886815,"median":16.972053,"eighty":51.009533,"marketCap":89007932145},{"date":"2021-09-17","current":17.393509,"twenty":5.886815,"median":17.123861,"eighty":51.009533,"marketCap":89785293998},{"date":"2021-09-24","current":17.291494,"twenty":5.886815,"median":17.235629,"eighty":51.009533,"marketCap":89258694033},{"date":"2021-10-01","current":16.652688,"twenty":5.886815,"median":17.235629,"eighty":51.009533,"marketCap":85961175206},{"date":"2021-10-08","current":16.528813,"twenty":5.886815,"median":17.235629,"eighty":51.009533,"marketCap":85321732392},{"date":"2021-10-15","current":16.426798,"twenty":5.886815,"median":17.235629,"eighty":51.009533,"marketCap":84795132427},{"date":"2021-10-22","current":16.33207,"twenty":5.886815,"median":17.235629,"eighty":51.009533,"marketCap":84306146745},{"date":"2021-10-29","current":11.012226,"twenty":5.886815,"median":17.235629,"eighty":51.009533,"marketCap":81424400000},{"date":"2021-11-05","current":11.251111,"twenty":5.886815,"median":17.235629,"eighty":51.009533,"marketCap":83190715179},{"date":"2021-11-12","current":11.447904,"twenty":5.893685,"median":17.235629,"eighty":51.009533,"marketCap":84645800064},{"date":"2021-11-19","current":11.653179,"twenty":5.897479,"median":17.235629,"eighty":51.009533,"marketCap":86163604126},{"date":"2021-11-26","current":11.921224,"twenty":5.918211,"median":17.235629,"eighty":51.009533,"marketCap":88145530090},{"date":"2021-12-03","current":11.800773,"twenty":6.026147,"median":17.235629,"eighty":51.009533,"marketCap":87254917790},{"date":"2021-12-10","current":11.917831,"twenty":6.210409,"median":17.235629,"eighty":51.009533,"marketCap":88120442420},{"date":"2021-12-17","current":12.250343,"twenty":6.275567,"median":17.235629,"eighty":51.009533,"marketCap":90579034123},{"date":"2021-12-23","current":12.296148,"twenty":6.286831,"median":17.235629,"eighty":51.009533,"marketCap":90917717674},{"date":"2021-12-31","current":12.318202,"twenty":6.311092,"median":17.235629,"eighty":51.009533,"marketCap":91080787532},{"date":"2022-01-07","current":12.089176,"twenty":6.331714,"median":17.2332,"eighty":50.998121,"marketCap":89387369777},{"date":"2022-01-14","current":12.175697,"twenty":6.376154,"median":17.2332,"eighty":50.998121,"marketCap":90027105373},{"date":"2022-01-21","current":11.622642,"twenty":6.392142,"median":17.2332,"eighty":50.998121,"marketCap":85937815092},{"date":"2022-01-28","current":11.682019,"twenty":6.427197,"median":17.2332,"eighty":50.998121,"marketCap":86376849324},{"date":"2022-02-04","current":12.876322,"twenty":6.478068,"median":17.2332,"eighty":50.998121,"marketCap":80155107055},{"date":"2022-02-11","current":12.507564,"twenty":6.506803,"median":17.2332,"eighty":50.998121,"marketCap":77859585210},{"date":"2022-02-18","current":12.302026,"twenty":6.55983,"median":17.2332,"eighty":50.998121,"marketCap":76580114018},{"date":"2022-02-25","current":12.311254,"twenty":6.578904,"median":17.2332,"eighty":50.998121,"marketCap":76637556570},{"date":"2022-03-04","current":12.46031,"twenty":6.599937,"median":17.2332,"eighty":50.998121,"marketCap":77565432746},{"date":"2022-03-11","current":11.6828,"twenty":6.635114,"median":17.2332,"eighty":50.998121,"marketCap":72725429992},{"date":"2022-03-18","current":11.968827,"twenty":6.678391,"median":17.2332,"eighty":50.998121,"marketCap":74505949140},{"date":"2022-03-25","current":11.884082,"twenty":6.698205,"median":17.2332,"eighty":50.998121,"marketCap":73978409872},{"date":"2022-04-01","current":12.037399,"twenty":8.02258,"median":17.2332,"eighty":50.998121,"marketCap":74932807962},{"date":"2022-04-08","current":12.567956,"twenty":8.716567,"median":17.2332,"eighty":50.998121,"marketCap":78235527670},{"date":"2022-04-14","current":12.471124,"twenty":8.90123,"median":17.2332,"eighty":50.998121,"marketCap":77632749929},{"date":"2022-04-22","current":12.55787,"twenty":9.141519,"median":17.2332,"eighty":50.998121,"marketCap":78172738322},{"date":"2022-04-29","current":16.504629,"twenty":9.361538,"median":17.2332,"eighty":50.998121,"marketCap":74518398265},{"date":"2022-05-06","current":16.996433,"twenty":10.809551,"median":17.239272,"eighty":50.998121,"marketCap":76738896748},{"date":"2022-05-13","current":17.327028,"twenty":11.245343,"median":17.247681,"eighty":50.998121,"marketCap":78231529751},{"date":"2022-05-20","current":17.735409,"twenty":11.419063,"median":17.289789,"eighty":50.998121,"marketCap":80075370520},{"date":"2022-05-27","current":18.002107,"twenty":11.443493,"median":17.319427,"eighty":50.998121,"marketCap":81279511430},{"date":"2022-06-03","current":17.627063,"twenty":11.598891,"median":17.34736,"eighty":50.998121,"marketCap":79586188275},{"date":"2022-06-10","current":16.874197,"twenty":11.674743,"median":17.353688,"eighty":50.998121,"marketCap":76186998831},{"date":"2022-06-17","current":16.260236,"twenty":11.693895,"median":17.353688,"eighty":50.998121,"marketCap":73414966111},{"date":"2022-06-24","current":17.524273,"twenty":11.796701,"median":17.385368,"eighty":51.009533,"marketCap":79122092299},{"date":"2022-07-01","current":17.32425,"twenty":11.863803,"median":17.393509,"eighty":51.009533,"marketCap":78218986617},{"date":"2022-07-08","current":17.457598,"twenty":11.905616,"median":17.41294,"eighty":51.009533,"marketCap":78821057072},{"date":"2022-07-15","current":17.390924,"twenty":11.935322,"median":17.41294,"eighty":51.009533,"marketCap":78520021844},{"date":"2022-07-22","current":16.890865,"twenty":11.980941,"median":17.41294,"eighty":51.009533,"marketCap":76262257638},{"date":"2022-07-29","current":16.599165,"twenty":12.028097,"median":17.41294,"eighty":51.009533,"marketCap":74945228518},{"date":"2022-08-05","current":18.52212,"twenty":12.086156,"median":17.427039,"eighty":51.009533,"marketCap":76626008538},{"date":"2022-08-12","current":19.074694,"twenty":12.171909,"median":17.456661,"eighty":51.009533,"marketCap":78912011126},{"date":"2022-08-19","current":19.795752,"twenty":12.222347,"median":17.478521,"eighty":51.009533,"marketCap":81895025523},{"date":"2022-08-26","current":18.895945,"twenty":12.254415,"median":17.529437,"eighty":51.009533,"marketCap":78172524363},{"date":"2022-09-02","current":19.335245,"twenty":12.287819,"median":17.577057,"eighty":51.009533,"marketCap":79989907085},{"date":"2022-09-09","current":19.777574,"twenty":12.303022,"median":17.627063,"eighty":51.009533,"marketCap":81819823480},{"date":"2022-09-16","current":19.874523,"twenty":12.328536,"median":17.735409,"eighty":51.009533,"marketCap":82220901046},{"date":"2022-09-23","current":19.044398,"twenty":12.37249,"median":17.877092,"eighty":51.009533,"marketCap":78786674386},{"date":"2022-09-30","current":18.689929,"twenty":12.440381,"median":18.002107,"eighty":51.009533,"marketCap":77320234535},{"date":"2022-10-07","current":19.477638,"twenty":12.472434,"median":18.174606,"eighty":51.009533,"marketCap":80578989760},{"date":"2022-10-14","current":20.047213,"twenty":12.542538,"median":18.389663,"eighty":51.009533,"marketCap":82935320460},{"date":"2022-10-21","current":20.538017,"twenty":12.806741,"median":18.504662,"eighty":51.009533,"marketCap":84965775639},{"date":"2022-10-28","current":29.80037,"twenty":13.013399,"median":18.615892,"eighty":51.009533,"marketCap":99354433322},{"date":"2022-11-04","current":30.22374,"twenty":13.251735,"median":18.662662,"eighty":51.009533,"marketCap":100765950507},{"date":"2022-11-11","current":30.780513,"twenty":13.37445,"median":18.717011,"eighty":51.009533,"marketCap":102622231397},{"date":"2022-11-18","current":31.45767,"twenty":13.431735,"median":18.843409,"eighty":51.009533,"marketCap":104879870318},{"date":"2022-11-25","current":32.450832,"twenty":13.459519,"median":18.879888,"eighty":51.009533,"marketCap":108191074069},{"date":"2022-12-02","current":33.4929,"twenty":13.504605,"median":18.899024,"eighty":51.009533,"marketCap":111665329520},{"date":"2022-12-09","current":33.09413,"twenty":13.606687,"median":18.972334,"eighty":51.009533,"marketCap":110335831044},{"date":"2022-12-16","current":32.638931,"twenty":13.64752,"median":19.040589,"eighty":51.009533,"marketCap":108818195992},{"date":"2022-12-23","current":31.882773,"twenty":13.702003,"median":19.108021,"eighty":51.009533,"marketCap":106297165863},{"date":"2022-12-30","current":32.296591,"twenty":13.772637,"median":19.194795,"eighty":51.009533,"marketCap":107676834093},{"date":"2023-01-06","current":33.135512,"twenty":13.805022,"median":19.238296,"eighty":51.009533,"marketCap":110473797867},{"date":"2023-01-13","current":32.454594,"twenty":13.873802,"median":19.29283,"eighty":51.009533,"marketCap":108203616508},{"date":"2023-01-20","current":31.228189,"twenty":13.90331,"median":19.320096,"eighty":51.009533,"marketCap":104114781573},{"date":"2023-01-27","current":31.499051,"twenty":13.995449,"median":19.384392,"eighty":51.009533,"marketCap":105017837141},{"date":"2023-02-03","current":22.946755,"twenty":14.041486,"median":19.450119,"eighty":51.009533,"marketCap":105371500000},{"date":"2023-02-10","current":23.544186,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":108114900000},{"date":"2023-02-17","current":23.017361,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":105695720000},{"date":"2023-02-24","current":21.905815,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":100591501721},{"date":"2023-03-03","current":22.017164,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":101102814834},{"date":"2023-03-10","current":21.59078,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":99144859743},{"date":"2023-03-17","current":20.996015,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":96413699455},{"date":"2023-03-24","current":21.756377,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":99905284240},{"date":"2023-03-31","current":22.564083,"twenty":14.066937,"median":19.46767,"eighty":50.998121,"marketCap":103614267917},{"date":"2023-04-06","current":22.749012,"twenty":14.066937,"median":19.46767,"eighty":50.998121,"marketCap":104463462833},{"date":"2023-04-14","current":22.645669,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":103988912733},{"date":"2023-04-21","current":23.031845,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":105762231528},{"date":"2023-04-28","current":18.688623,"twenty":14.055938,"median":19.442338,"eighty":51.020944,"marketCap":104338581228},{"date":"2023-05-05","current":17.542922,"twenty":14.055938,"median":19.3806,"eighty":51.020944,"marketCap":97942133140},{"date":"2023-05-12","current":17.583137,"twenty":14.055938,"median":19.319381,"eighty":51.020944,"marketCap":98166656624},{"date":"2023-05-19","current":17.473662,"twenty":14.050438,"median":19.278218,"eighty":51.032356,"marketCap":97555453806},{"date":"2023-05-26","current":17.348547,"twenty":14.044939,"median":19.233751,"eighty":51.043768,"marketCap":96856936300},{"date":"2023-06-02","current":17.026822,"twenty":14.044939,"median":19.162011,"eighty":51.043768,"marketCap":95060748428},{"date":"2023-06-08","current":16.997778,"twenty":14.044939,"median":19.104641,"eighty":51.043768,"marketCap":94898592579},{"date":"2023-06-16","current":17.650163,"twenty":14.039759,"median":19.040589,"eighty":51.200274,"marketCap":98540862431},{"date":"2023-06-23","current":17.45132,"twenty":14.038033,"median":18.973525,"eighty":51.252442,"marketCap":97430718537},{"date":"2023-06-30","current":16.982138,"twenty":14.036306,"median":18.920182,"eighty":51.304611,"marketCap":94811277890},{"date":"2023-07-07","current":17.033525,"twenty":14.036306,"median":18.886384,"eighty":51.304611,"marketCap":95098169009},{"date":"2023-07-14","current":17.138532,"twenty":14.036306,"median":18.848464,"eighty":51.304611,"marketCap":95684424773},{"date":"2023-07-21","current":17.860178,"twenty":14.036306,"median":18.770739,"eighty":51.304611,"marketCap":99713373958},{"date":"2023-07-28","current":17.093848,"twenty":14.036306,"median":18.679091,"eighty":51.304611,"marketCap":95434954235},{"date":"2023-08-04","current":17.179531,"twenty":14.036306,"median":18.633127,"eighty":51.304611,"marketCap":94212548600},{"date":"2023-08-11","current":18.176723,"twenty":14.036306,"median":18.52212,"eighty":51.304611,"marketCap":99681148240},{"date":"2023-08-18","current":17.381491,"twenty":14.036306,"median":18.429012,"eighty":51.304611,"marketCap":95320098004},{"date":"2023-08-25","current":17.342866,"twenty":14.036306,"median":18.328953,"eighty":51.304611,"marketCap":95108275564},{"date":"2023-09-01","current":17.376947,"twenty":14.036306,"median":18.1949,"eighty":51.304611,"marketCap":95295177717},{"date":"2023-09-08","current":16.799836,"twenty":14.036306,"median":18.174606,"eighty":51.304611,"marketCap":92130301260},{"date":"2023-09-15","current":17.576891,"twenty":14.036306,"median":18.052169,"eighty":51.304611,"marketCap":96391670348},{"date":"2023-09-22","current":17.102024,"twenty":14.036306,"median":17.993772,"eighty":51.304611,"marketCap":93787500350},{"date":"2023-09-29","current":17.136105,"twenty":14.036306,"median":17.876807,"eighty":51.304611,"marketCap":93974402503},{"date":"2023-10-06","current":16.972515,"twenty":14.036306,"median":17.771527,"eighty":51.304611,"marketCap":93077272169},{"date":"2023-10-13","current":17.440566,"twenty":14.036306,"median":17.722305,"eighty":51.304611,"marketCap":95644061736},{"date":"2023-10-19","current":18.101744,"twenty":14.036306,"median":17.689975,"eighty":51.304611,"marketCap":99269963503},{"date":"2023-10-27","current":17.835909,"twenty":14.029482,"median":17.676863,"eighty":51.032356,"marketCap":97812126710},{"date":"2023-11-03","current":18.45619,"twenty":14.029482,"median":17.650163,"eighty":33.471833,"marketCap":101213745894},{"date":"2023-11-10","current":15.89997,"twenty":14.029482,"median":17.641227,"eighty":33.09714,"marketCap":93428221287},{"date":"2023-11-17","current":15.802424,"twenty":14.029482,"median":17.615533,"eighty":32.981271,"marketCap":92855042015},{"date":"2023-11-24","current":15.984792,"twenty":14.029482,"median":17.59511,"eighty":32.559177,"marketCap":93926638045},{"date":"2023-12-01","current":16.243501,"twenty":14.029482,"median":17.57082,"eighty":32.289819,"marketCap":95446809157},{"date":"2023-12-08","current":16.550982,"twenty":14.031188,"median":17.55419,"eighty":32.133321,"marketCap":97253569904},{"date":"2023-12-15","current":17.341951,"twenty":14.031188,"median":17.52836,"eighty":32.07012,"marketCap":101901306173},{"date":"2023-12-22","current":16.737591,"twenty":14.031188,"median":17.504184,"eighty":31.887287,"marketCap":98350086772},{"date":"2023-12-29","current":17.206235,"twenty":14.029482,"median":17.486007,"eighty":31.764,"marketCap":101103839360},{"date":"2024-01-05","current":17.914503,"twenty":14.027776,"median":17.48476,"eighty":31.6075,"marketCap":105265619289},{"date":"2024-01-12","current":18.107474,"twenty":14.027776,"median":17.48476,"eighty":31.532333,"marketCap":106399517414},{"date":"2024-01-19","current":18.321651,"twenty":14.024373,"median":17.483513,"eighty":31.465946,"marketCap":107658019728},{"date":"2024-01-26","current":17.013264,"twenty":14.027776,"median":17.475784,"eighty":31.443073,"marketCap":99969941235},{"date":"2024-02-02","current":16.574308,"twenty":14.027776,"median":17.458344,"eighty":31.344417,"marketCap":97390634513},{"date":"2024-02-09","current":16.232638,"twenty":14.027776,"median":17.458344,"eighty":31.344417,"marketCap":91957891851},{"date":"2024-02-16","current":16.138057,"twenty":14.027776,"median":17.458344,"eighty":31.344417,"marketCap":91422093836},{"date":"2024-02-23","current":16.008284,"twenty":14.027776,"median":17.458344,"eighty":31.344417,"marketCap":90686929118},{"date":"2024-03-01","current":15.855313,"twenty":14.029482,"median":17.457598,"eighty":31.337724,"marketCap":89820349813},{"date":"2024-03-08","current":16.198369,"twenty":14.029482,"median":17.457598,"eighty":31.337724,"marketCap":91763758214},{"date":"2024-03-15","current":16.319318,"twenty":14.029482,"median":17.457598,"eighty":31.337724,"marketCap":92448934253},{"date":"2024-03-22","current":16.073021,"twenty":14.029482,"median":17.457598,"eighty":31.337724,"marketCap":91053666683},{"date":"2024-03-28","current":16.055429,"twenty":14.029482,"median":17.457598,"eighty":31.337724,"marketCap":90954004714},{"date":"2024-04-05","current":15.309217,"twenty":14.027776,"median":17.458344,"eighty":31.344417,"marketCap":86726715023},{"date":"2024-04-12","current":15.111111,"twenty":14.027776,"median":17.458344,"eighty":31.344417,"marketCap":85604442650},{"date":"2024-04-19","current":14.563017,"twenty":14.027776,"median":17.458344,"eighty":31.344417,"marketCap":82499489086},{"date":"2024-04-26","current":167.813786,"twenty":14.029482,"median":17.45909,"eighty":31.35376,"marketCap":81389686406},{"date":"2024-05-03","current":167.968051,"twenty":14.029482,"median":17.475896,"eighty":31.454751,"marketCap":81464504564},{"date":"2024-05-10","current":165.891135,"twenty":14.029482,"median":17.490666,"eighty":31.502061,"marketCap":80457200237},{"date":"2024-05-17","current":174.305702,"twenty":14.043532,"median":17.524273,"eighty":31.57906,"marketCap":84538265441},{"date":"2024-05-24","current":169.975478,"twenty":14.043532,"median":17.54896,"eighty":31.623197,"marketCap":82438106839},{"date":"2024-05-31","current":164.60675,"twenty":14.10774,"median":17.565264,"eighty":31.836928,"marketCap":79834273632},{"date":"2024-06-07","current":164.015933,"twenty":14.265245,"median":17.579161,"eighty":32.047548,"marketCap":79547727394},{"date":"2024-06-14","current":163.27099,"twenty":14.274228,"median":17.606597,"eighty":32.082158,"marketCap":79186429964},{"date":"2024-06-21","current":175.935023,"twenty":14.272576,"median":17.621828,"eighty":32.181475,"marketCap":85328486284},{"date":"2024-06-28","current":176.808405,"twenty":14.267619,"median":17.642004,"eighty":32.289819,"marketCap":85752076375},{"date":"2024-07-05","current":171.054361,"twenty":14.267619,"median":17.658975,"eighty":32.499738,"marketCap":82961365187},{"date":"2024-07-12","current":179.736802,"twenty":14.267619,"median":17.687689,"eighty":32.981271,"marketCap":87172349033},{"date":"2024-07-15","current":179.711114,"twenty":14.267619,"median":17.696211,"eighty":33.038453,"marketCap":87159890501},{"date":"2024-08-02","current":196.485179,"twenty":14.529265,"median":17.810595,"eighty":33.095635,"marketCap":95295311956},{"date":"2024-08-09","current":89.28743,"twenty":14.761123,"median":17.860178,"eighty":33.429699,"marketCap":94108951402},{"date":"2024-08-16","current":87.810922,"twenty":15.064446,"median":17.910429,"eighty":56.284205,"marketCap":92552711301},{"date":"2024-08-23","current":89.653604,"twenty":15.441554,"median":17.994613,"eighty":57.705461,"marketCap":94494898947},{"date":"2024-08-30","current":93.846889,"twenty":15.739388,"median":18.052169,"eighty":58.207525,"marketCap":98914620835},{"date":"2024-09-06","current":93.043668,"twenty":15.813085,"median":18.107474,"eighty":58.39978,"marketCap":98068026220},{"date":"2024-09-13","current":98.229166,"twenty":15.851395,"median":18.176723,"eighty":59.168901,"marketCap":103533541455},{"date":"2024-09-20","current":99.10326,"twenty":15.88894,"median":18.219893,"eighty":59.37255,"marketCap":104454835595},{"date":"2024-09-27","current":98.087422,"twenty":15.920691,"median":18.287258,"eighty":59.81346,"marketCap":103384142406},{"date":"2024-10-04","current":99.422185,"twenty":15.979621,"median":18.356937,"eighty":60.090264,"marketCap":104790983457},{"date":"2024-10-11","current":100.012789,"twenty":16.007608,"median":18.435741,"eighty":60.321593,"marketCap":105413479498},{"date":"2024-10-18","current":103.190235,"twenty":16.047512,"median":18.510381,"eighty":60.845545,"marketCap":108762508196},{"date":"2024-10-25","current":104.867549,"twenty":16.062334,"median":18.540053,"eighty":61.800519,"marketCap":110530396951},{"date":"2024-10-31","current":104.288758,"twenty":16.062334,"median":18.540053,"eighty":63.846895,"marketCap":109920350831},{"date":"2024-11-08","current":968.122222,"twenty":16.060766,"median":18.539019,"eighty":65.503766,"marketCap":121983400000},{"date":"2024-11-15","current":911.059905,"twenty":16.060766,"median":18.539019,"eighty":67.314857,"marketCap":114793548088},{"date":"2024-11-22","current":887.816058,"twenty":16.060766,"median":18.539019,"eighty":87.499083,"marketCap":111864823324},{"date":"2024-11-29","current":915.708675,"twenty":16.060766,"median":18.539019,"eighty":88.564531,"marketCap":115379293041},{"date":"2024-12-06","current":923.720384,"twenty":16.060766,"median":18.539019,"eighty":90.934033,"marketCap":116388768385},{"date":"2024-12-13","current":913.730475,"twenty":16.060766,"median":18.539019,"eighty":93.40748,"marketCap":115130039869},{"date":"2024-12-20","current":900.971087,"twenty":16.060766,"median":18.539019,"eighty":95.961249,"marketCap":113522356914},{"date":"2024-12-27","current":933.809203,"twenty":16.060766,"median":18.539019,"eighty":98.094509,"marketCap":117659959559},{"date":"2025-01-03","current":908.784976,"twenty":16.060766,"median":18.539019,"eighty":98.88828,"marketCap":114506906941},{"date":"2025-01-10","current":881.683639,"twenty":16.059197,"median":18.537985,"eighty":99.141058,"marketCap":111092138492},{"date":"2025-01-17","current":906.510046,"twenty":16.059197,"median":18.537985,"eighty":99.880493,"marketCap":114220265794},{"date":"2025-01-24","current":919.071615,"twenty":16.059197,"median":18.537985,"eighty":100.438024,"marketCap":115803023432},{"date":"2025-01-31","current":958.93234,"twenty":16.059197,"median":18.537985,"eighty":102.332679,"marketCap":120825474836},{"date":"2025-02-07","current":969.713529,"twenty":16.09178,"median":18.615892,"eighty":104.116302,"marketCap":122183904620},{"date":"2025-02-14","current":275.113188,"twenty":16.111578,"median":18.662662,"eighty":105.609347,"marketCap":132054330207},{"date":"2025-02-21","current":285.680484,"twenty":16.147709,"median":18.689929,"eighty":162.793199,"marketCap":137126632245},{"date":"2025-02-28","current":290.769403,"twenty":16.147709,"median":18.808017,"eighty":164.216297,"marketCap":139569313325},{"date":"2025-03-07","current":301.06241,"twenty":16.143392,"median":18.87176,"eighty":165.27463,"marketCap":144509957034},{"date":"2025-03-14","current":294.083284,"twenty":16.164977,"median":18.897485,"eighty":166.913912,"marketCap":141159976127},{"date":"2025-03-21","current":274.676641,"twenty":16.17325,"median":18.953832,"eighty":167.968051,"marketCap":131844787583},{"date":"2025-03-28","current":288.401392,"twenty":16.17325,"median":19.023685,"eighty":168.716781,"marketCap":138432668251},{"date":"2025-04-04","current":291.592591,"twenty":16.17325,"median":19.104641,"eighty":171.054361,"marketCap":139964443908},{"date":"2025-04-11","current":263.079356,"twenty":16.173436,"median":19.194795,"eighty":173.515242,"marketCap":126278090686},{"date":"2025-04-17","current":272.389631,"twenty":16.173436,"median":19.238296,"eighty":174.142022,"marketCap":130747023108},{"date":"2025-04-25","current":22.184451,"twenty":16.17325,"median":19.285524,"eighty":176.243276,"marketCap":132330248884},{"date":"2025-05-02","current":21.578375,"twenty":16.17325,"median":19.297177,"eighty":176.243276,"marketCap":128715008924},{"date":"2025-05-09","current":20.470089,"twenty":16.17325,"median":19.297177,"eighty":176.243276,"marketCap":122104082517},{"date":"2025-05-16","current":20.924702,"twenty":16.17325,"median":19.309817,"eighty":176.243276,"marketCap":124815848001},{"date":"2025-05-23","current":22.259345,"twenty":16.17325,"median":19.375544,"eighty":176.243276,"marketCap":132776994375},{"date":"2025-05-30","current":23.170656,"twenty":16.17325,"median":19.403352,"eighty":176.243276,"marketCap":138212964634},{"date":"2025-06-06","current":23.035107,"twenty":16.17325,"median":19.46767,"eighty":176.243276,"marketCap":137404410705},{"date":"2025-06-13","current":23.366682,"twenty":16.17325,"median":19.52123,"eighty":176.243276,"marketCap":139382258008},{"date":"2025-06-20","current":22.522103,"twenty":16.167278,"median":19.629121,"eighty":176.258689,"marketCap":134344345068},{"date":"2025-06-27","current":22.442859,"twenty":16.167278,"median":19.72304,"eighty":176.258689,"marketCap":133871652002},{"date":"2025-07-03","current":23.304121,"twenty":16.167278,"median":19.777574,"eighty":176.258689,"marketCap":139009079271},{"date":"2025-07-11","current":23.885942,"twenty":16.167278,"median":19.874523,"eighty":176.258689,"marketCap":142479641519},{"date":"2025-07-18","current":22.688934,"twenty":16.167278,"median":20.047213,"eighty":176.258689,"marketCap":135339488364},{"date":"2025-07-25","current":23.606501,"twenty":16.167278,"median":20.135073,"eighty":176.258689,"marketCap":140812776497},{"date":"2025-08-01","current":23.416731,"twenty":16.193531,"median":20.515968,"eighty":176.258689,"marketCap":139680800997},{"date":"2025-08-08","current":21.73673,"twenty":16.230379,"median":20.924702,"eighty":176.258689,"marketCap":137180503463},{"date":"2025-08-15","current":23.400545,"twenty":16.265509,"median":21.375144,"eighty":176.258689,"marketCap":147680839142},{"date":"2025-08-22","current":22.834308,"twenty":16.329624,"median":21.49301,"eighty":176.258689,"marketCap":144107315224},{"date":"2025-08-29","current":22.130443,"twenty":16.387413,"median":21.593495,"eighty":176.258689,"marketCap":139665226464},{"date":"2025-09-05","current":22.171731,"twenty":16.4349,"median":21.646285,"eighty":176.274101,"marketCap":139925795917},{"date":"2025-09-12","current":23.172477,"twenty":16.509435,"median":21.73673,"eighty":176.258689,"marketCap":146241503119},{"date":"2025-09-19","current":22.33885,"twenty":16.547758,"median":21.802614,"eighty":176.258689,"marketCap":140980481795},{"date":"2025-09-26","current":21.821765,"twenty":16.572129,"median":22.017164,"eighty":176.258689,"marketCap":137717159606},{"date":"2025-10-03","current":21.737223,"twenty":16.611295,"median":22.028027,"eighty":176.258689,"marketCap":137183612632},{"date":"2025-10-10","current":22.952274,"twenty":16.651672,"median":22.107199,"eighty":176.258689,"marketCap":144851799373},{"date":"2025-10-17","current":23.170511,"twenty":16.731298,"median":22.14224,"eighty":176.258689,"marketCap":146229095050},{"date":"2025-10-24","current":23.738714,"twenty":16.778677,"median":22.171731,"eighty":176.258689,"marketCap":149815027037},{"date":"2025-10-31","current":18.120983,"twenty":16.795866,"median":22.184451,"eighty":176.258689,"marketCap":146961171131},{"date":"2025-11-07","current":18.898002,"twenty":16.795866,"median":22.144649,"eighty":176.258689,"marketCap":153262800000},{"date":"2025-11-14","current":19.153279,"twenty":16.795866,"median":22.11668,"eighty":176.258689,"marketCap":155333088799},{"date":"2025-11-21","current":19.121152,"twenty":16.795866,"median":22.040002,"eighty":176.258689,"marketCap":155072546078},{"date":"2025-11-28","current":19.254246,"twenty":16.795866,"median":21.968279,"eighty":176.258689,"marketCap":156151937350},{"date":"2025-12-05","current":18.758586,"twenty":16.795866,"median":21.821765,"eighty":176.258689,"marketCap":152132135372},{"date":"2025-12-12","current":18.848845,"twenty":16.795866,"median":21.756377,"eighty":176.258689,"marketCap":152864136349},{"date":"2025-12-19","current":18.582658,"twenty":16.795866,"median":21.664107,"eighty":176.258689,"marketCap":150705353805},{"date":"2025-12-26","current":19.22518,"twenty":16.795866,"median":21.623369,"eighty":176.258689,"marketCap":155916208222},{"date":"2026-01-02","current":18.776944,"twenty":16.795866,"median":21.579916,"eighty":176.258689,"marketCap":152281016927},{"date":"2026-01-09","current":18.460273,"twenty":16.795866,"median":21.456002,"eighty":176.258689,"marketCap":149712810107},{"date":"2026-01-16","current":18.550532,"twenty":16.795866,"median":21.131806,"eighty":176.258689,"marketCap":150444811084},{"date":"2026-01-23","current":20.061988,"twenty":16.795866,"median":20.904605,"eighty":176.258689,"marketCap":162702725760},{"date":"2026-01-30","current":21.348562,"twenty":16.795866,"median":20.79477,"eighty":176.258689,"marketCap":173136841389},{"date":"2026-02-06","current":22.85084,"twenty":16.795866,"median":20.79477,"eighty":174.722564,"marketCap":185320315287},{"date":"2026-02-13","current":22.1325,"twenty":16.795866,"median":20.79477,"eighty":173.804449,"marketCap":188347573567},{"date":"2026-02-20","current":22.031904,"twenty":16.795866,"median":20.79477,"eighty":172.268409,"marketCap":187491504627},{"date":"2026-02-27","current":20.972859,"twenty":16.795866,"median":20.79477,"eighty":169.624219,"marketCap":178479029310},{"date":"2026-03-06","current":21.172712,"twenty":16.795866,"median":20.79477,"eighty":168.328001,"marketCap":180179775433},{"date":"2026-03-13","current":21.182923,"twenty":16.795866,"median":20.79477,"eighty":167.61653,"marketCap":180266674870},{"date":"2026-03-20","current":20.584824,"twenty":16.795866,"median":20.611082,"eighty":165.952785,"marketCap":175176850706},{"date":"2026-03-27","current":19.964567,"twenty":16.795866,"median":20.470089,"eighty":164.868764,"marketCap":169898469139},{"date":"2026-04-02","current":20.46339,"twenty":16.795866,"median":20.259289,"eighty":164.031346,"marketCap":174143448423},{"date":"2026-04-10","current":20.72447,"twenty":16.795866,"median":20.244608,"eighty":117.698348,"marketCap":176365235827},{"date":"2026-04-15","current":20.485268,"twenty":16.795866,"median":20.244608,"eighty":105.247898,"marketCap":174329631725}],"updateTime":1776384342575},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GILD\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2626190948","title":"Morgan Stanley Reaffirms Their Buy Rating on Gilead Sciences (GILD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2626190948","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626190948?lang=en_us&edition=fundamental","pubTime":"2026-04-10 20:29","pubTimestamp":1775824185,"startTime":"0","endTime":"0","summary":"In a report released today, Terence Flynn from Morgan Stanley maintained a Buy rating on Gilead Sciences, with a price target of $175.00. Flynn cov...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/morgan-stanley-reaffirms-their-buy-rating-on-gilead-sciences-gild-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/morgan-stanley-reaffirms-their-buy-rating-on-gilead-sciences-gild-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GILD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626104197","title":"Cantor Fitzgerald Adjusts Price Target on Gilead Sciences to $115 From $155, Maintains Overweight Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2626104197","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626104197?lang=en_us&edition=fundamental","pubTime":"2026-04-10 20:16","pubTimestamp":1775823388,"startTime":"0","endTime":"0","summary":"Gilead Sciences (GILD) has an average rating of overweight and mean price target of $160.44, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from m","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GILD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626155312","title":"Gilead expects Q1 acquired IPR&D charge of about $107 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2626155312","media":"Reuters","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626155312?lang=en_us&edition=fundamental","pubTime":"2026-04-10 06:09","pubTimestamp":1775772573,"startTime":"0","endTime":"0","summary":"Gilead forecast Q1 2026 acquired IPR&D expense of about $107 million.Charge expected to reduce GAAP diluted EPS by about $0.07.Estimate includes an $80 million upfront payment tied to Genhouse collaboration announced Feb. 13, 2026.Full-year 2026 IPR&D guidance of $300 million issued Feb. 10, 2026 excluded Genhouse payment.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gilead Sciences Inc. published the original content used to generate this news brief on April 09, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nNDL4VLsjq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066051498.USD","BK4588","LU1037948897.HKD","LU1430594728.SGD","IE00B19Z3581.USD","LU1934455277.USD","BK4532","LU0234570918.USD","LU0289739699.SGD","BK4139","IE00B7SZLL34.SGD","LU1057294990.SGD","LU0823416689.USD","LU1023059063.AUD","LU0861579265.USD","BK4585","LU0965508806.USD","LU0965509283.SGD","LU1571399168.USD","LU2087621335.USD","BK4568","GILD","IE00BKVL7J92.USD","LU1674673428.USD","LU2089984988.USD","BK4578","LU0882574055.USD","LU1778281490.HKD","LU1037948541.HKD","LU1674673691.USD","SG9999015952.SGD","LU1066053197.SGD","IE00BSNM7G36.USD","SG9999015945.SGD","LU0965509101.SGD","IE0002270589.USD","LU0320765992.SGD","SG9999015986.USD","SG9999015978.USD","LU2112291526.USD","LU0114720955.EUR","LU0122379950.USD","LU1934455194.USD","LU1585245621.USD","LU0109394709.USD","LU0889565916.HKD","LU1934455863.HKD","IE00B19Z3B42.SGD","IE00BZ1G4Q59.USD","LU1839511570.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626133542","title":"Tempus AI announce strategic collaboration with Gilead","url":"https://stock-news.laohu8.com/highlight/detail?id=2626133542","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626133542?lang=en_us&edition=fundamental","pubTime":"2026-04-09 22:18","pubTimestamp":1775744333,"startTime":"0","endTime":"0","summary":"Tempus AI (TEM) announced an expanded, multi-year collaboration with Gilead Sciences (GILD) aimed at building and advancing Gilead’s oncology pipel...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tempus-ai-announce-strategic-collaboration-with-gilead-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tempus-ai-announce-strategic-collaboration-with-gilead-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TEM","LU1066051498.USD","LU1066053197.SGD","BK4566","AIYY","SG9999015952.SGD","IE00BKVL7J92.USD","LU1585245621.USD","BK4585","LU1037948897.HKD","LU1057294990.SGD","IE00B19Z3581.USD","BK4587","LU0823416689.USD","LU0234570918.USD","LU1037948541.HKD","BK4528","BK4611","LU0882574055.USD","BK4578","LU0965508806.USD","TEMT","LU0965509010.AUD","LU0109394709.USD","LU2089984988.USD","SG9999015986.USD","BK4543","SG9999015945.SGD","LU1934455863.HKD","SG9999015978.USD","BK4613","LU0122379950.USD","LU0058720904.USD","IE00BSNM7G36.USD","LU1430594728.SGD","LU1674673428.USD","LU1778281490.HKD","LU0965509283.SGD","LU1839511570.USD","IE00BZ1G4Q59.USD","GILD","LU1934455194.USD","IE00B7SZLL34.SGD","LU0289739699.SGD","IE00B3T34201.USD","LU1571399168.USD","LU1861559042.SGD","LU1934455277.USD","LU2112291526.USD","BK4023","LU0114720955.EUR","LU0320765992.SGD","LU0861579265.USD","LU1023059063.AUD","LU2087621335.USD","LU2324357040.USD","IE00B19Z3B42.SGD","BK4121","BK4139","IE0002270589.USD","BK4551","LU1674673691.USD","LU2468319806.SGD","BK4550","BK4583","LU0889565916.HKD","LU0965509101.SGD","LU1061106388.HKD","BK4568","BK4588","LU1861558580.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626182743","title":"BUZZ-Tempus AI rises as it expands cancer research partnership with Gilead","url":"https://stock-news.laohu8.com/highlight/detail?id=2626182743","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626182743?lang=en_us&edition=fundamental","pubTime":"2026-04-09 20:49","pubTimestamp":1775738983,"startTime":"0","endTime":"0","summary":"BUZZ-Tempus AI rises as it expands cancer research partnership with Gilead** Shares of healthcare AI firm Tempus AI TEM.O rise 1.5% to $47.99 premarket** Co says it has expanded its multi-year partnership with Gilead GILD.O to support cancer drug research** Collaboration gives Gilead wider access to Tempus’ real-world patient data and AI tools, which analyze medical records from cancer patients - TEM** Gilead will use the platform to design clinical trials, choose drug targets and study treatment outcomes, co says** Says partnership aims to speed up development of cancer medicines by combining Tempus’ data insights with Gilead’s drugmaking expertise** Gilead has previously utilized TEM's data for its oncology research, including trial design, health outcomes analysis and clinical evidence** As of last close, stock down ~20% YTD","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nL4N40S11A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","BK4588","BK4532","SG9999015952.SGD","BK4613","GILD","IE00B7SZLL34.SGD","LU1430594728.SGD","BK4583","LU0109394709.USD","LU0114720955.EUR","LU0234570918.USD","LU1037948897.HKD","LU1023059063.AUD","IE00B19Z3B42.SGD","BK4611","LU0823416689.USD","LU1037948541.HKD","BK4139","BK4121","LU1066053197.SGD","IE00B3T34201.USD","LU0320765992.SGD","LU1839511570.USD","LU1934455194.USD","LU1674673428.USD","LU1934455863.HKD","LU2112291526.USD","LU2468319806.SGD","LU1778281490.HKD","IE00B19Z3581.USD","IE00BZ1G4Q59.USD","LU1057294990.SGD","LU0058720904.USD","IE0002270589.USD","BK4566","LU2089984988.USD","TEMT","LU1934455277.USD","LU0889565916.HKD","LU0965508806.USD","BK4550","TEM","LU0965509101.SGD","LU1585245621.USD","LU1066051498.USD","LU1674673691.USD","BK4568","LU1061106388.HKD","SG9999015978.USD","LU1861559042.SGD","LU0882574055.USD","LU1861558580.USD","LU2087621335.USD","BK4585","LU0289739699.SGD","SG9999015986.USD","LU0965509010.AUD","BK4578","LU0965509283.SGD","LU1571399168.USD","IE00BSNM7G36.USD","LU0861579265.USD","LU0122379950.USD","SG9999015945.SGD","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626182530","title":"Tempus Announces Strategic Collaboration With Gilead to Advance Oncology R&D Through RWE","url":"https://stock-news.laohu8.com/highlight/detail?id=2626182530","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626182530?lang=en_us&edition=fundamental","pubTime":"2026-04-09 20:31","pubTimestamp":1775737909,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nFWN40S0FD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TEM","GILD","BK4611","TEMT","LU1861559042.SGD","BK4613","LU1861558580.USD","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626825641","title":"Tempus expands multi-year oncology RWE collaboration with Gilead Sciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2626825641","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626825641?lang=en_us&edition=fundamental","pubTime":"2026-04-09 20:31","pubTimestamp":1775737874,"startTime":"0","endTime":"0","summary":"Tempus AI expanded a multi-year strategic collaboration with Gilead Sciences to support Gilead oncology R&D using real-world evidence.Expanded agreement grants Gilead enterprise-wide access to Tempus Lens platform, including broader oncology datasets.Gilead will also use dedicated Tempus analytical services to support oncology pipeline development.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tempus AI Inc. published the original content used to generate this news brief via Business Wire  on April 09, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nNDLbVZ0Yw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066051498.USD","BK4588","TEMT","BK4583","LU1037948897.HKD","LU1430594728.SGD","IE00B19Z3581.USD","LU1934455277.USD","BK4532","BK4566","LU0234570918.USD","LU0289739699.SGD","LU1061106388.HKD","BK4139","IE00B7SZLL34.SGD","LU0058720904.USD","LU1057294990.SGD","LU0823416689.USD","LU1023059063.AUD","LU0861579265.USD","BK4585","LU0965508806.USD","BK4121","BK4611","LU0965509283.SGD","LU1571399168.USD","LU2087621335.USD","LU2324357040.USD","BK4568","GILD","IE00BKVL7J92.USD","IE00B3T34201.USD","LU1674673428.USD","LU1861558580.USD","LU2089984988.USD","BK4578","LU0882574055.USD","LU1861559042.SGD","LU1778281490.HKD","LU1037948541.HKD","LU1674673691.USD","SG9999015952.SGD","LU1066053197.SGD","IE00BSNM7G36.USD","BK4613","SG9999015945.SGD","LU0965509101.SGD","IE0002270589.USD","LU0320765992.SGD","SG9999015986.USD","SG9999015978.USD","LU2112291526.USD","LU0114720955.EUR","LU0122379950.USD","LU1934455194.USD","BK4550","TEM","LU1585245621.USD","LU0109394709.USD","LU0889565916.HKD","LU1934455863.HKD","IE00B19Z3B42.SGD","LU2468319806.SGD","IE00BZ1G4Q59.USD","LU1839511570.USD","LU0965509010.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626618466","title":"Assembly Bio highlights positive Phase 1b HSV data for ABI-5366 at ESCMID 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2626618466","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626618466?lang=en_us&edition=fundamental","pubTime":"2026-04-09 20:08","pubTimestamp":1775736533,"startTime":"0","endTime":"0","summary":"Assembly Bio flagged positive Phase 1b data for HSV drug candidates ABI-5366 and ABI-1179 in recurrent genital herpes ahead of scientific presentations at ESCMID Global 2026 in Munich on April 17-21.ABI-5366 results will be presented in an oral session on April 20, including additional findings from a monthly-dosing cohort.ABI-1179 interim Phase 1b results were accepted for a late-breaker poster on April 21, supporting its positioning as a long-acting option for recurrent genital herpes.Both programs remain investigational and are licensed exclusively to Gilead, which holds responsibility for further development and commercialization.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nNDL2yMkmk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0882574055.USD","ASMB","LU1571399168.USD","IE00BN0W2W23.USD","IE00B3QW5Z07.USD","LU1934455863.HKD","LU2468319806.SGD","LU1057294990.SGD","BK4578","BK4583","LU0823416689.USD","LU1934455194.USD","IE00BKVL7J92.USD","IE00BN0W2T93.GBP","BK4568","LU1037948541.HKD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","LU1839511570.USD","LU2112291526.USD","SG9999014021.USD","SG9999014039.USD","SG9999015986.USD","SG9999015978.USD","GILD","BK4532","LU0122379950.USD","LU0965509283.SGD","LU1674673428.USD","IE00BN0W2V16.EUR","LU2089984988.USD","BK4139","IE00BZ1G4Q59.USD","LU2087621335.USD","LU0889565916.HKD","LU1066051498.USD","LU2324357040.USD","BK4550","LU1934455277.USD","SG9999014013.SGD","LU0861579265.USD","IE00BSNM7G36.USD","IE00B64PRP62.GBP","LU0965509010.AUD","LU2210149790.SGD","SG9999014005.SGD","LU1585245621.USD","LU0234570918.USD","NDAQ","LU1023059063.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626189777","title":"Cartography Biosciences: Advances Strategic Oncology Collaboration With Gilead's First Option Target Exercise","url":"https://stock-news.laohu8.com/highlight/detail?id=2626189777","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626189777?lang=en_us&edition=fundamental","pubTime":"2026-04-09 19:34","pubTimestamp":1775734451,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nFWN40S0CM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1057294990.SGD","LU1037948541.HKD","SG9999015986.USD","LU0122379950.USD","LU0320765992.SGD","LU1430594728.SGD","LU1066051498.USD","IE00B19Z3581.USD","LU1839511570.USD","BK4532","LU0289739699.SGD","IE00BZ1G4Q59.USD","BK4585","LU2112291526.USD","IE0002270589.USD","LU0234570918.USD","IE00BSNM7G36.USD","IE00B3T34201.USD","BK4578","LU1934455863.HKD","BK4588","LU1674673428.USD","LU0882574055.USD","IE00B7SZLL34.SGD","BK4568","LU0109394709.USD","LU0965509101.SGD","BK4583","LU1585245621.USD","LU2324357040.USD","IE00BKVL7J92.USD","IE00B19Z3B42.SGD","LU0965508806.USD","SG9999015952.SGD","SG9999015978.USD","LU1778281490.HKD","GILD","LU0114720955.EUR","BK4566","LU1066053197.SGD","LU1934455194.USD","BK4139","LU0965509010.AUD","LU1674673691.USD","LU0889565916.HKD","LU2087621335.USD","LU0058720904.USD","LU0965509283.SGD","LU0823416689.USD","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626318962","title":"BUZZ-Kymera rises as Gilead pays $45 million for experimental cancer drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2626318962","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626318962?lang=en_us&edition=fundamental","pubTime":"2026-04-09 19:20","pubTimestamp":1775733628,"startTime":"0","endTime":"0","summary":"BUZZ-Kymera rises as Gilead pays $45 million for experimental cancer drug** Shares of biotech firm Kymera Therapeutics KYMR.O rise 3% to $89.50 premarket** Co says it will receive $45 million upfront from Gilead Sciences GILD.O to license KT-200, an experimental oral cancer drug** KT-200 targets CDK2, a protein that helps tumors grow; the drug is designed to remove the protein entirely, which could improve effectiveness and reduce side effects - KYMR** Co says the drug could help treat hardtotreat cancers such as advanced breast cancer, where treatment options are limited** Adds that Gilead gets global rights and will lead further development, aiming to start human studies in 2027** Says Kymera could receive up to $750 million in total payments plus royalties if the drug is approved** As of last close, stock up ~12% YTD","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nL4N40S0V1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","GILD","IE00B19Z3581.USD","LU1934455277.USD","LU0965508806.USD","BK4588","IE00B3T34201.USD","KYMR","IE00BZ1G4Q59.USD","LU0289739699.SGD","LU1066051498.USD","LU1066053197.SGD","LU0109394709.USD","LU1674673691.USD","BK4568","LU2087621335.USD","LU2089984988.USD","LU1571399168.USD","LU1057294990.SGD","SG9999015945.SGD","LU1674673428.USD","BK4139","LU0058720904.USD","LU0861579265.USD","IE00B7SZLL34.SGD","LU1037948541.HKD","LU0114720955.EUR","SG9999015952.SGD","LU1430594728.SGD","LU0320765992.SGD","LU1839511570.USD","BK4566","BK4578","LU1934455863.HKD","LU1023059063.AUD","LU1934455194.USD","LU1061106388.HKD","LU1585245621.USD","BK4583","LU2112291526.USD","IE0002270589.USD","LU0965509010.AUD","IE00BKVL7J92.USD","LU2324357040.USD","SG9999015978.USD","LU0234570918.USD","LU0882574055.USD","LU2468319806.SGD","IE00BSNM7G36.USD","BK4550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626186243","title":"Kymera Therapeutics Announces Gilead Sciences’ Option Exercise to License KT-200, Oral CDK2 Molecular Glue Degrader Development Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2626186243","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626186243?lang=en_us&edition=fundamental","pubTime":"2026-04-09 19:00","pubTimestamp":1775732400,"startTime":"0","endTime":"0","summary":"KT-200 is a first-in-class, oral CDK2 molecular glue degrader development candidate Option exercise of KT-200 triggers a $45 million milestone payment to Kymera from Gilead Sciences WATERTOWN, Mass., ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/09/3270789/0/en/Kymera-Therapeutics-Announces-Gilead-Sciences-Option-Exercise-to-License-KT-200-Oral-CDK2-Molecular-Glue-Degrader-Development-Candidate.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BSNM7G36.USD","LU0109394709.USD","LU1066053197.SGD","BK4568","LU1061106388.HKD","LU0289739699.SGD","BK4588","BK4583","LU2089984988.USD","LU0122379950.USD","GILD","LU0965509010.AUD","BK4115","SG9999015945.SGD","LU1023059063.AUD","BK4585","LU1674673691.USD","LU1430594728.SGD","LU0114720955.EUR","LU0234570918.USD","BK4550","SG9999015952.SGD","SG9999015986.USD","LU0823416689.USD","LU0861579265.USD","LU2324357040.USD","LU1778281490.HKD","LU0889565916.HKD","IE00BKVL7J92.USD","LU1674673428.USD","IE0002270589.USD","LU1057294990.SGD","LU1585245621.USD","LU0058720904.USD","KYMR","SG9999015978.USD","LU0882574055.USD","IE00B7SZLL34.SGD","LU1934455194.USD","IE00BZ1G4Q59.USD","IE00B19Z3B42.SGD","LU0541501648.USD","LU2468319806.SGD","LU1934455863.HKD","LU0965508806.USD","LU1571399168.USD","KT","IE00B19Z3581.USD","BK4566","BK4578"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626922059","title":"Gilead Sciences Inc. Stock Rises Wednesday, Still Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2626922059","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626922059?lang=en_us&edition=fundamental","pubTime":"2026-04-09 04:34","pubTimestamp":1775680440,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  rallied 1.97% to $141.54 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 2.51% to 6,782.81 and the Dow Jones Industrial Average  rising 2.85% to 47,909.92.Gilead Sciences Inc. closed 10.01% below its 52-week high of $157.29, which the company achieved on February 11th.The stock outperformed some of its competitors Wednesday, as Johnson & Johnson  rose 1.21% to $241.30, Pfizer Inc.  rose 1.37% to $27.47, and Abbott Laboratories  rose 1.70% to $103.56.Trading volume  remained 2.2 million below its 50-day average volume of 7.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled April 8, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2602419157.SGD","IE00B4R5TH58.HKD","IE00BKVL7J92.USD","LU0426412945.USD","LU0795875086.SGD","IE00B7SZLL34.SGD","BK4082","LU2505996509.AUD","BK4581","LU0321505439.SGD","LU0306807586.USD","LU0689626769.HKD","LU1074936037.SGD","LU1571399168.USD","IE00BJT1NW94.SGD","LU2087621335.USD","LU1430594728.SGD","LU0912757837.SGD","IE00BFTCPJ56.SGD","LU1066053197.SGD","LU0640476718.USD","IE000WAW04H5.SGD","SG9999001440.SGD","LU1032466523.USD","LU2129689431.USD","LU0792757196.USD","IE00BDGV0183.EUR","IE00BFXG1179.USD","LU0787776722.HKD","LU2430703095.HKD","IE0002270589.USD","BK4550","IE00BVYPNW00.USD","GILD","LU1221951129.SGD","LU0861579265.USD","SG9999013999.USD","LU0306806265.USD","IE00BLSP4239.USD","LU1066051811.HKD","LU1894683264.USD","LU0234572021.USD","BK4566","LU0124676726.USD","LU1721429741.USD","LU1674673428.USD","IE00BJJMRZ35.SGD","LU0965509283.SGD","LU1162221912.USD","SG9999001176.SGD","LU1032955483.USD","IE00BGHQF631.EUR","LU0098860793.USD","LU1023059063.AUD","IE000MB6IJN5.SGD","SG9999004303.SGD","LU1244550494.USD","IE000BZT7R73.USD","LU0965509101.SGD","LU1721429402.USD","LU1934455194.USD","LU1066051498.USD","LU1674673691.USD","LU1066051225.USD","SG9999002224.SGD","BK4007","LU1043141123.HKD","LU1037948541.HKD","SG9999015945.SGD","LU1585245621.USD","LU0795875169.SGD","LU0234570918.USD","LU1732799900.SGD","LU1196500208.SGD","LU0345770993.USD","LU1983299246.USD","LU0965508806.USD","LU0203347892.USD","LU1037948897.HKD","LU1934455863.HKD","LU0070217475.USD","SG9999015986.USD","LU0320765992.SGD","IE0034235303.USD","LU1989763427.SGD","LU2129689605.HKD","LU0203345920.USD","LU1929549753.HKD","BK4533","IE00B1BXHZ80.USD","LU0289739699.SGD","LU0985320562.USD","LU0170899867.USD","LU2471134879.HKD","LU1718418525.SGD","LU2211815571.USD","LU2471134952.CNY","SG9999015978.USD","SGXZ23171101.USD","LU1496350502.SGD","IE0009355771.USD","IE00BBT3K403.USD","LU2430703178.SGD","LU0994945656.USD","LU1261432733.SGD","LU2347655156.SGD","IE00B2B36J28.USD","LU1061106388.HKD","LU0320765646.SGD","LU0345769128.USD","LU1732800096.USD","SG9999011175.SGD","LU1989763690.USD","BK4139","IE000M9KFDE8.USD","LU0985481810.HKD","SG9999001176.USD","LU1839511570.USD","IE00B3PB1722.GBP","LU0882574055.USD","BK4599","BK4559","LU1244550221.USD","IE0002141913.USD","LU2750360641.GBP","LU2468319806.SGD","LU1267930813.SGD","LU0345769631.USD","IE000F7OJYX1.SGD","LU2471134523.USD","SG9999015952.SGD","LU0683600562.USD","LU1221951046.USD","LU2505996681.GBP","LU0266013472.USD","BK4583","BK4532","LU1691799644.USD","LU0058720904.USD","LU0225771236.USD","IE00BSNM7G36.USD","LU2750360997.AUD","LU1043141396.HKD","LU1059921491.USD","IE0000B7K699.USD","LU0965509010.AUD","LU1280957306.USD","IE00BVYPNV92.GBP","SGXZ41872573.SGD","LU2471134796.USD","SG9999003800.SGD","LU1914381329.SGD","SG9999002232.USD","LU2324357040.USD","LU2112291526.USD","LU1057294990.SGD","IE00B3T34201.USD","BK4504","LU0889565916.HKD","LU1883839398.USD","IE0001KFT4U8.USD","LU2592432038.USD","LU0823416689.USD","LU1934455277.USD","LU1935042991.SGD","LU2237957811.SGD","LU0868494617.USD","BK4585","LU0109394709.USD","LU2129689514.USD","IE000SO60NU8.SGD","LU0456855351.SGD","IE00B19Z3B42.SGD","LU1244550577.SGD","LU1121112475.USD","IE00BLSP4452.SGD","LU0426417589.USD","LU2089984988.USD","BK4592","BK4578","IE00BN8TJ469.HKD","SGXZ57979304.SGD","IE00B42XCP33.USD","LU2133065610.SGD","IE00B19Z3581.USD","LU0321505868.SGD","LU2237957902.USD","LU0466842654.USD","BK4534","LU0432979614.USD","BK4568","LU0114720955.EUR","BK4588","LU0122379950.USD","LU0225284248.USD","LU1506573853.SGD","LU1894683348.USD","IE00BZ1G4Q59.USD","LU0889566641.SGD","LU1778281490.HKD","LU0345770308.USD","LU2430703251.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625832928","title":"Gilead Sciences' Tubulis Buy Underscores Shift Beyond HIV, Oppenheimer Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2625832928","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625832928?lang=en_us&edition=fundamental","pubTime":"2026-04-08 23:06","pubTimestamp":1775660786,"startTime":"0","endTime":"0","summary":"Gilead Sciences  agreed to acquire Tubulis for $5 billion, its \"third takeout\" in six weeks as it pushes to diversify beyond its \"core focus on HIV,\" Oppenheimer said in a report Wednesday.The deal follows the recent takeovers of Arcellx  and Ouro, representing a total capital outlay of roughly $15 billion. Analysts at the firm view the latest moves as a strategic effort for \"adding shots on goal\" to Gilead's pipeline, particularly in oncology and autoimmune diseases, the report said, adding that Gilead currently generates about 30% of its revenue outside of infectious diseases.While the \"shopping spree\" highlights a decade-long shift toward cancer and inflammatory treatments, near-term focus for investors is squarely on the launch of Yeztugo, a drug in the company's HIV prevention and treatment lineup, according to the report.Gilead is also supported by high operating margins and a \"dividend yield\" of about 3% to 4%, positioning the company for further growth, Oppenheimer said.Oppenhe","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","LU0882574055.USD","IE00BKVL7J92.USD","LU2112291526.USD","BK4127","BK4566","LU0965509101.SGD","BK4578","SG9999015986.USD","SG9999015945.SGD","OPY","LU2087621335.USD","IE00B19Z3B42.SGD","IE00BSNM7G36.USD","LU0320765992.SGD","LU1066051498.USD","LU1934455194.USD","LU1037948541.HKD","LU2468319806.SGD","BK4583","LU0122379950.USD","IE00B19Z3581.USD","IE00BZ1G4Q59.USD","BK4550","BK4532","ACLX","LU0114720955.EUR","LU1674673428.USD","LU1839511570.USD","LU0289739699.SGD","BK4568","LU0965508806.USD","LU1778281490.HKD","LU0823416689.USD","LU1037948897.HKD","LU1066053197.SGD","LU2089984988.USD","GILD","LU0234570918.USD","LU1430594728.SGD","LU1585245621.USD","IE00B3T34201.USD","SG9999015952.SGD","BK4139","LU0058720904.USD","LU1057294990.SGD","LU1571399168.USD","BK4588","LU2324357040.USD","LU1023059063.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625941883","title":"Gilead price target raised to $155 from $152 at Truist","url":"https://stock-news.laohu8.com/highlight/detail?id=2625941883","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625941883?lang=en_us&edition=fundamental","pubTime":"2026-04-08 20:27","pubTimestamp":1775651225,"startTime":"0","endTime":"0","summary":"Truist analyst Gregory Renza raised the firm’s price target on Gilead (GILD) to $155 from $152 and keeps a Buy rating on the shares as part of a br...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gilead-price-target-raised-to-155-from-152-at-truist-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gilead-price-target-raised-to-155-from-152-at-truist-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1585245621.USD","LU1934455194.USD","BK4588","BK4550","LU1061106388.HKD","SG9999015978.USD","LU2468319806.SGD","LU0889565916.HKD","IE00BKVL7J92.USD","BK4578","IE00BSNM7G36.USD","LU1037948541.HKD","LU1778281490.HKD","LU2087621335.USD","LU1839511570.USD","LU0058720904.USD","BK4566","SG9999015986.USD","LU0114720955.EUR","LU1674673691.USD","GILD","LU1571399168.USD","IE00BZ1G4Q59.USD","LU2112291526.USD","LU0965508806.USD","IE00B3T34201.USD","LU0234570918.USD","LU0882574055.USD","IE0002270589.USD","LU0289739699.SGD","LU1674673428.USD","IE00B7SZLL34.SGD","LU2324357040.USD","LU1023059063.AUD","SG9999015945.SGD","BK4139","LU1066051498.USD","SG9999015952.SGD","LU2089984988.USD","LU0965509283.SGD","LU0823416689.USD","LU0109394709.USD","LU0320765992.SGD","LU0965509010.AUD","LU1037948897.HKD","LU1057294990.SGD","IE00B19Z3581.USD","BK4585","IE00B19Z3B42.SGD","LU0861579265.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625945267","title":"BUZZ-Truist lifts Gilead PT on expectations of in-line Q1 results","url":"https://stock-news.laohu8.com/highlight/detail?id=2625945267","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625945267?lang=en_us&edition=fundamental","pubTime":"2026-04-08 19:47","pubTimestamp":1775648867,"startTime":"0","endTime":"0","summary":"BUZZ-Truist lifts Gilead PT on expectations of in-line Q1 results** Truist Securities raises PT on drugmaker Gilead Sciences GILD.O to $155 from $152, maintains rating at \"buy\"** New PT represents an 11.7% upside to the stock's last close** Truist expects Q1 results to be broadly in line with Wall Street estimates** Expects revenue of $6.94 bln vs analysts' consensus $6.91 bln and non-GAAP EPS of $1.84 vs consensus of $1.90** Estimates Q1 HIV drug Biktarvy sales of $3.30 bln vs Street expectations of $3.34 bln; sees PrEP drug Yeztugo sales of $167 mln vs expectations of $151 mln     ** Expects Q1 commentary on Yeztugo launch strategy and payer access in the U.S. and EU** To watch out for updates on blood cancer therapy anito-cel launch preparations ahead of December 23 PDUFA date** Anticipates discussion on recent M&A activity, including Ouro and Tubulis, and other near-term growth drivers such as Livdelzi amid evolving liver-disease competition** 26 of 33 brokerages rate the stock \"bu","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260408:nL4N40R10P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","SG9999015978.USD","IE00B7SZLL34.SGD","IE00BZ1G4Q59.USD","LU1023059063.AUD","LU0122379950.USD","LU1430594728.SGD","LU0234570918.USD","LU0114720955.EUR","LU1778281490.HKD","BK4585","LU0823416689.USD","LU0320765992.SGD","LU0861579265.USD","LU0965508806.USD","BK4583","LU1571399168.USD","IE00B19Z3581.USD","LU1934455277.USD","LU0109394709.USD","BK4578","LU0882574055.USD","LU0058720904.USD","LU0965509010.AUD","IE00BSNM7G36.USD","LU1037948897.HKD","BK4532","IE00B19Z3B42.SGD","LU1037948541.HKD","LU1934455863.HKD","LU2468319806.SGD","LU1674673428.USD","BK4139","SG9999015952.SGD","BK4550","LU2324357040.USD","IE00B3T34201.USD","LU0889565916.HKD","BK4568","BK4588","BK4566","LU1066053197.SGD","LU1839511570.USD","GILD","LU1934455194.USD","LU2112291526.USD","SG9999015986.USD","LU1066051498.USD","IE00BKVL7J92.USD","LU1057294990.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625459719","title":"Gilead Sciences: Strategic Oncology Expansion and Undervalued Growth Opportunity Driving Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2625459719","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625459719?lang=en_us&edition=fundamental","pubTime":"2026-04-08 19:35","pubTimestamp":1775648142,"startTime":"0","endTime":"0","summary":"Gilead Sciences, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Evan Seigerman from BMO Capital maintaine...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/gilead-sciences-strategic-oncology-expansion-and-undervalued-growth-opportunity-driving-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/gilead-sciences-strategic-oncology-expansion-and-undervalued-growth-opportunity-driving-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GILD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625917924","title":"Gilead’s Tubulis Acquisition: Building an ADC Oncology Franchise and Enhancing Risk‑Reward for GILD Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2625917924","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625917924?lang=en_us&edition=fundamental","pubTime":"2026-04-08 17:45","pubTimestamp":1775641543,"startTime":"0","endTime":"0","summary":"In a report released today, Joseph Stringer from Needham maintained a Buy rating on Gilead Sciences, with a price target of $170.00. Joseph Stringe...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/gileads-tubulis-acquisition-building-an-adc-oncology-franchise-and-enhancing-risk‑reward-for-gild-shares-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/gileads-tubulis-acquisition-building-an-adc-oncology-franchise-and-enhancing-risk‑reward-for-gild-shares-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1037948541.HKD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","LU2087621335.USD","SG9999015952.SGD","LU1585245621.USD","LU1061106388.HKD","SG9999015986.USD","LU0234570918.USD","BK4578","BK4231","LU0122379950.USD","LU0320765992.SGD","LU0882574055.USD","LU0289739699.SGD","LU0965509010.AUD","LU1023059063.AUD","SG9999015945.SGD","BK4585","LU0889565916.HKD","LU0109394709.USD","LU0058720904.USD","LU1934455277.USD","BK4080","LU1674673691.USD","IE00B19Z3581.USD","LU1057294990.SGD","LU1430594728.SGD","BK4568","SG9999015978.USD","LU1778281490.HKD","LU1066053197.SGD","LU0823416689.USD","LU1839511570.USD","LU2112291526.USD","LU0965509101.SGD","IE00B7SZLL34.SGD","ADC","BK4139","LU1037948897.HKD","IE00B3T34201.USD","IE0002270589.USD","LU0114720955.EUR","GILD","LU1571399168.USD","LU2324357040.USD","LU1674673428.USD","IE00B19Z3B42.SGD","BK4583","LU0965509283.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625950939","title":"Leerink says Tubulis deal highlights value of ADC platforms like Sutro’s","url":"https://stock-news.laohu8.com/highlight/detail?id=2625950939","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625950939?lang=en_us&edition=fundamental","pubTime":"2026-04-08 01:30","pubTimestamp":1775583048,"startTime":"0","endTime":"0","summary":"Leerink analyst Andrew Berens notes Gilead (GILD) announced plans to acquire Tubulis for $3.15B in cash plus up to $1.85B in contingent milestone p...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/leerink-says-tubulis-deal-highlights-value-of-adc-platforms-like-sutros-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/leerink-says-tubulis-deal-highlights-value-of-adc-platforms-like-sutros-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4583","LU1037948541.HKD","LU2112291526.USD","LU1934455277.USD","LU0965509101.SGD","BK4080","LU2468319806.SGD","LU1066051498.USD","LU0122379950.USD","LU1778281490.HKD","IE00B19Z3581.USD","BK4585","LU2087621335.USD","LU0289739699.SGD","LU1023059063.AUD","IE00BKVL7J92.USD","LU2324357040.USD","BK4231","LU0320765992.SGD","SG9999015945.SGD","LU1839511570.USD","LU1057294990.SGD","LU0965508806.USD","LU0109394709.USD","IE00B7SZLL34.SGD","BK4139","SG9999015986.USD","LU0234570918.USD","BK4578","LU0965509283.SGD","LU0882574055.USD","IE00BZ1G4Q59.USD","LU1061106388.HKD","LU1430594728.SGD","ADC","BK4588","BK4532","IE00B19Z3B42.SGD","LU0861579265.USD","LU2089984988.USD","BK4568","LU1934455863.HKD","GILD","LU0114720955.EUR","IE00B3T34201.USD","BK4550","LU1571399168.USD","LU0889565916.HKD","LU0965509010.AUD","LU1934455194.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625690950","title":"Leerink sees Gilead’s $5B Tubulis buy as ‘more than an oncology bolt-on’","url":"https://stock-news.laohu8.com/highlight/detail?id=2625690950","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625690950?lang=en_us&edition=fundamental","pubTime":"2026-04-08 01:25","pubTimestamp":1775582738,"startTime":"0","endTime":"0","summary":"Leerink notes Gilead (GILD) announced a definitive agreement to acquire privately held Tubulis for a total potential deal value of $5B. The firm li...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/leerink-sees-gileads-5b-tubulis-buy-as-more-than-an-oncology-bolt-on-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/leerink-sees-gileads-5b-tubulis-buy-as-more-than-an-oncology-bolt-on-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1778281490.HKD","LU1839511570.USD","LU2324357040.USD","LU0289739699.SGD","SG9999015978.USD","LU0965509101.SGD","BK4550","LU2087621335.USD","LU0122379950.USD","LU0965509010.AUD","LU1037948897.HKD","LU1057294990.SGD","LU1066051498.USD","IE00B19Z3B42.SGD","BK4588","LU2112291526.USD","IE00B7SZLL34.SGD","LU0234570918.USD","SG9999015986.USD","BK4578","LU2468319806.SGD","SG9999015952.SGD","IE0002270589.USD","BK4532","LU1430594728.SGD","IE00BKVL7J92.USD","LU0965508806.USD","LU1585245621.USD","LU1934455194.USD","BK4139","LU1066053197.SGD","GILD","LU1934455277.USD","LU1674673691.USD","IE00B19Z3581.USD","LU1037948541.HKD","LU0114720955.EUR","LU0889565916.HKD","LU1023059063.AUD","LU0882574055.USD","LU0320765992.SGD","SG9999015945.SGD","IE00B3T34201.USD","IE00BSNM7G36.USD","LU0861579265.USD","LU1061106388.HKD","LU1571399168.USD","LU1674673428.USD","LU1934455863.HKD","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625957096","title":"Gilead Sciences (GILD) Gets a Buy from Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2625957096","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625957096?lang=en_us&edition=fundamental","pubTime":"2026-04-08 01:15","pubTimestamp":1775582134,"startTime":"0","endTime":"0","summary":"Cantor Fitzgerald analyst Carter Gould maintained a Buy rating on Gilead Sciences on April 5 and set a price target of $155.00. According to TipRan...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/gilead-sciences-gild-gets-a-buy-from-cantor-fitzgerald-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/gilead-sciences-gild-gets-a-buy-from-cantor-fitzgerald-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1057294990.SGD","SG9999015986.USD","LU0122379950.USD","LU0320765992.SGD","SG9999015945.SGD","LU0861579265.USD","LU1430594728.SGD","LU1839511570.USD","BK4532","IE00BZ1G4Q59.USD","BK4585","LU2112291526.USD","LU1571399168.USD","IE0002270589.USD","LU0234570918.USD","LU1023059063.AUD","IE00BSNM7G36.USD","IE00B3T34201.USD","BK4578","LU1934455863.HKD","BK4588","LU0882574055.USD","IE00B7SZLL34.SGD","BK4568","LU0109394709.USD","LU0965509101.SGD","BK4550","LU2468319806.SGD","LU2324357040.USD","LU1585245621.USD","IE00BKVL7J92.USD","LU0965508806.USD","SG9999015952.SGD","SG9999015978.USD","LU1037948897.HKD","LU1778281490.HKD","GILD","LU0114720955.EUR","BK4566","LU1066053197.SGD","LU1934455194.USD","BK4139","LU0965509010.AUD","LU1674673691.USD","LU0889565916.HKD","LU2087621335.USD","LU0058720904.USD","LU0965509283.SGD","LU0823416689.USD","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}